secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2021-11-19T23:59:59+00:00
Accession:  0001472375-21-000139
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Peptide Technologies names Gregory Pilant CEO/Chairman, Deborah Pilant Secretary/Treasurer
--------------------------------------------------------------------------------

- Gregory P. Pilant appointed CEO and Chairman of the Board effective Nov 16, 2021; Deborah L. Pilant appointed Secretary/Treasurer.
- Dennis Cox and Irene Getty resigned from Board of Directors effective Nov 16, 2021.
- Bruce Sellars resigned as CEO but remains on Board; Byron Striloff resigned as President effective Nov 16, 2021.
- Dr. Lee Ori appointed as Chief Operating Officer effective Nov 16, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-21-000139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer